Jo Jerman

Jo Jerman is the Head of Emerging Medicines in BioPharmaceuticals Medical, focusing on Respiratory and Immunology at AstraZeneca. They previously served as a Pharmaceutical Equity Analyst at Citigroup from 2004 to 2013 and held multiple leadership roles at AstraZeneca from 2014 to 2016, including Director of Respiratory, Inflammation and Autoimmune. Jo is currently pursuing a Doctor of Philosophy (PhD) in Molecular Biology at St. George's, University of London, and a Master of Arts (MA) in Biochemistry at the University of Oxford.